Gene · 6480
Papers1,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Host Cell Response to Rotavirus Infection with Emphasis on Virus-Glycan Interactions, Cholesterol Metabolism, and Innate Immunity. | Viruses | 2023 | 37515094 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor-α G-308A Polymorphism and Sporadic IgA Nephropathy: A Meta-Analysis Using a Genetic Model-Free Approach. | Genes (Basel) | 2023 | 37510392 | PubTator, text mining | PubMed |
| A unique maternal and placental galectin signature upon SARS-CoV-2 infection suggests galectin-1 as a key alarmin at the maternal-fetal interface. | Front Immunol | 2023 | 37475853 | PubTator, text mining | PubMed |
| Contemporary human H3N2 influenza A viruses require a low threshold of suitable glycan receptors for efficient infection. | Glycobiology | 2023 | 37471650 | PubTator, text mining | PubMed |
| H3N2 influenza A virus gradually adapts to human-type receptor binding and entry specificity after the start of the 1968 pandemic. | Proc Natl Acad Sci U S A | 2023 | 37467282 | PubTator, text mining | PubMed |
| Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes. | mBio | 2023 | 37466314 | PubTator, text mining | PubMed |
| Altered profile of glycosylated proteins in serum samples obtained from patients with Hashimoto's thyroiditis following depletion of highly abundant proteins. | Front Immunol | 2023 | 37457741 | PubTator, text mining | PubMed |
| Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37457652 | PubTator, text mining | PubMed |
| Development of small fluorescent probes for the analysis of autophagy kinetics. | iScience | 2023 | 37456828 | PubTator, text mining | PubMed |
| Focal-adhesion kinase regulates the sialylation of N-glycans via the PI4KIIα-PI4P pathway. | J Biol Chem | 2023 | 37451482 | PubTator, text mining | PubMed |
| Extracellular vesicles improve GABAergic transmission in Huntington's disease iPSC-derived neurons. | Theranostics | 2023 | 37441602 | PubTator, text mining | PubMed |
| Hyper α2,6-Sialylation Promotes CD4+ T-Cell Activation and Induces the Occurrence of Ulcerative Colitis. | Adv Sci (Weinh) | 2023 | 37424034 | PubTator, text mining | PubMed |
| Targeting host sialic acids in the upper respiratory tract with a broadly-acting neuraminidase to inhibit influenza virus transmission. | bioRxiv | 2023 | 37398388 | PubTator, text mining | PubMed |
| IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition. | Res Sq | 2023 | 37398192 | PubTator, text mining | PubMed |
| Effect of Borrelia burgdorferi on the Expression of miRNAs in Breast Cancer and Normal Mammary Epithelial Cells. | Microorganisms | 2023 | 37374977 | PubTator, text mining | PubMed |
| Correlation of Serum N-Acetylneuraminic Acid with the Risk of Moyamoya Disease. | Brain Sci | 2023 | 37371391 | PubTator, text mining | PubMed |
| Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism. | Glycobiology | 2023 | 37364046 | PubTator, text mining | PubMed |
| A Strategic Research Framework for Defeating Diabetes in India: A 21st-Century Agenda. | J Indian Inst Sci | 2023 | 37362852 | PubTator, text mining | PubMed |
| A Novel Vision of Reinforcing Nanofibrous Masks with Metal Nanoparticles: Antiviral Mechanisms Investigation. | Adv Fiber Mater | 2023 | 37361103 | PubTator, text mining | PubMed |
| Polymeric biomaterial-inspired cell surface modulation for the development of novel anticancer therapeutics. | Biomater Res | 2023 | 37344853 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6480/papers?page=11